期刊文献+
共找到2篇文章
< 1 >
每页显示 20 50 100
Perioperative challenges in management of diabetic patients undergoing non-cardiac surgery 被引量:6
1
作者 Ursula Galway Praveen Chahar +4 位作者 Marc T Schmidt Jorge A Araujo-Duran Jeevan Shivakumar alparslan turan Kurt Ruetzler 《World Journal of Diabetes》 SCIE 2021年第8期1255-1266,共12页
Prediabetes and diabetes are important disease processes which have several perioperative implications.About one third of the United States population is considered to have prediabetes.The prevalence in surgical patie... Prediabetes and diabetes are important disease processes which have several perioperative implications.About one third of the United States population is considered to have prediabetes.The prevalence in surgical patients is even higher.This is due to the associated micro and macrovascular complications of diabetes that result in the need for subsequent surgical procedures.A careful preoperative evaluation of diabetic patients and patients at risk for prediabetes is essential to reduce perioperative mortality and morbidity.This preoperative evaluation involves an optimization of preoperative comorbidities.It also includes optimization of antidiabetic medication regimens,as the avoidance of unintentional hypoglycemic and hyperglycemic episodes during the perioperative period is crucial.The focus of the perioperative management is to ensure euglycemia and thus improve postoperative outcomes.Therefore,prolonged preoperative fasting should be avoided and close monitoring of blood glucose should be initiated and continued throughout surgery.This can be accomplished with either analysis in blood gas samples,venous phlebotomy or point-of-care testing.Although capillary and arterial whole blood glucose do not meet standard guidelines for glucose testing,they can still be used to guide insulin dosing in the operating room.Intraoperative glycemic control goals may vary slightly in different protocols but overall the guidelines suggest a glucose range in the operating room should be between 140 mg/dL to 180 mg/dL.When hyperglycemia is detected in the operating room,blood glucose management may be initiated with subcutaneous rapid-acting insulin,with intravenous infusion or boluses of regular insulin.Fluid and electrolyte management are other perioperative challenges.Notably diabetic ketoacidosis and hyperglycemic hyperosmolar nonketotic state are the two most serious acute metabolic complications of diabetes that must be recognized early and treated. 展开更多
关键词 Diabetes mellitus Perioperative management INSULIN HYPERGLYCAEMIA ANAESTHESIA SURGERY
下载PDF
经皮尼古丁贴剂无助于改善手术后疼痛
2
作者 alparslan turan Paul F. White +5 位作者 Onur Koyuncu Beyhan Karamanlio u Gaye Kaya Christian C. Apfel 翁美琳(译) 杜冬萍(校) 《麻醉与镇痛》 2010年第4期27-33,共7页
背景有报道称经鼻单次给予3mg尼古丁有镇痛作用。为了验证这个假说,我们设计了安慰剂一对照研究,旨在验证下腹部手术后,经皮尼古丁贴剂(transdermal nicotine,TDN)应用3天是否缓解手术后疼痛,减少阿片类止痛药的用量,改善恢复... 背景有报道称经鼻单次给予3mg尼古丁有镇痛作用。为了验证这个假说,我们设计了安慰剂一对照研究,旨在验证下腹部手术后,经皮尼古丁贴剂(transdermal nicotine,TDN)应用3天是否缓解手术后疼痛,减少阿片类止痛药的用量,改善恢复进程。方法97例接受下腹部子宫切除术的患者被随机分配到两个治疗小组:(1)对照组在手术前1小时和手术后2天给予无作用的贴剂;(2)尼古丁组在麻醉诱导前1小时和手术后2天给予TDN30(21mg尼古丁)贴剂。两组的麻醉方式相同,手术后评估包括:疼痛镇静语言等级量表、静脉患者自控镇痛吗啡用量、恢复质量评分、肠功能恢复、正常活动能力恢复、患者对疼痛治疗的满意度。手术后1和3个月随访,以评价后期恢复情况。结果患者自控镇痛吗啡用量、仰卧位或坐位时疼痛评分、手术中芬太尼用量、口服止痛药用量、肠鸣音的恢复以及胃肠胀气的消失等指标在两组中都没有差异。尽管恢复活动时间、住院时间和恢复质量的评分两组间没有差异,但是尼古丁组恢复饮食的时间延长。与对照组相比,尼古丁组在手术后48和72小时的出院合格评分更高,但是两组患者返回工作的时间都是19天。结论对盆腔妇科手术的患者,围手术期使用大剂量的尼古丁贴剂并不能改善手术后镇痛的效果,或减少止痛药的需求。虽然尼古丁组在进食的恢复时间上较迟,但是更多的患者在手术后48和72小时就能达到出院的标准。不过,两组重新恢复日常生活能力的时间相似。 展开更多
关键词 尼古丁贴剂 手术后疼痛 静脉患者自控镇痛 阿片类止痛药 下腹部手术后 质量评分 日常生活能力 子宫切除术
原文传递
上一页 1 下一页 到第
使用帮助 返回顶部